HHS Removes Hormone Therapy Warnings: Informed Consent and Health Risks

HHS Decision on Hormone Therapy Warnings

• ⚠️ The Department of Health and Human Services (HHS) has announced the removal of long-standing warning labels from hormone replacement therapy (HRT) for menopausal women.
• 💡 Previously, these labels warned of associations with breast cancer and other contraindications, but HHS claims these were based on outdated studies.
• 📉 The removal is seen by some as effectively rebranding HRT as safe, potentially marketing it to women.

Concerns Over New Data and Informed Consent

• ❓ HHS has not presented new data to support the safety of HRT; instead, a panel reviewed existing studies.
• 📊 The original warnings stemmed from a 2002 Women's Health Initiative study linking combined hormone therapy to increased breast cancer risk, which HHS now deems overly broad or faulty.
• 🚫 Critics argue that removing warnings hinders full consumer consent, as HRT carries documented risks like blood clots, strokes, and cardiovascular events.
• 📈 There is also a lack of clear guidance on how to safely discontinue HRT, often leading to prolonged use.

Pharmaceutical Industry Influence and Profit

• 💰 The decision is noted as potentially profitable for pharmaceutical companies like Fizer and Novo Nordisk, also makers of injectable weight-loss drugs.
• 🤝 Questions are raised about favorable deals these companies receive from the White House.

Expert Perspectives on HRT Risks and Benefits

• 🩺 Dr. Marian Mass, a pediatrician and HRT patient, emphasizes that all medications have side effects and prefers treatments with established data.
• 💡 She shares a personal experience of severe hot flashes leading to injury, but also notes that HRT can reduce risks of Alzheimer's, fractures, and improve sleep and brain fog.
• ⚠️ Dr. Mass acknowledges the risk of blood clots and advises consultation with a doctor, especially for those with clotting disorders.
• 🗣️ The discussion highlights the nuance needed, differentiating between types of HRT (e.g., oral vs. pelleted injections) and the role of pharmacy benefit managers.

Historical Context and Future Considerations

• 📜 A parallel is drawn to the birth control pill, which was marketed without full disclosure of risks like stroke.
• 🧠 The concern is that women may feel they can never come off HRT if they feel good on it, without knowing when it might become detrimental.
• 🔬 The importance of nuanced discussion and questioning science is stressed, as science is never truly settled.
• 📈 There is a call for more doctors who critically evaluate studies and for continued research into alternatives and long-term HRT effects.